The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2025

Filed:

Oct. 20, 2021
Applicant:

Longhorn Vaccines and Diagnostics, Llc, Bethesda, MD (US);

Inventors:

Jeffrey D. Fischer, Washington, DC (US);

Clara J. Sei, Germantown, MD (US);

Luke T. Daum, San Antonio, TX (US);

Gerald W. Fischer, Bethesda, MD (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/02 (2006.01); A61K 39/04 (2006.01); A61K 39/09 (2006.01); A61K 39/095 (2006.01); A61K 39/102 (2006.01); A61K 39/116 (2006.01); A61K 39/385 (2006.01); A61K 47/64 (2017.01); A61P 31/16 (2006.01); A61P 37/04 (2006.01); A61K 39/00 (2006.01); A61K 39/145 (2006.01);
U.S. Cl.
CPC ...
A61K 39/116 (2013.01); A61K 39/04 (2013.01); A61K 39/092 (2013.01); A61K 39/095 (2013.01); A61K 39/102 (2013.01); A61K 39/385 (2013.01); A61K 47/6415 (2017.08); A61K 47/646 (2017.08); A61P 31/16 (2018.01); A61P 37/04 (2018.01); A61K 39/145 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/53 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/6043 (2013.01); A61K 2039/6068 (2013.01); A61K 2039/70 (2013.01);
Abstract

The invention relates to composite antigens comprising an antigen obtained or derived from an antigenic epitope of one or more pathogens that induces an immune response in a mammal, an antigen obtained or derived from bacterial cell wall material that induces an immune response in a mammal such as LTA, PNG or LPS, and a T cell stimulating antigen such as CRM. Preferably the composite antigen comprises an immunogenic composition or a vaccine that is effective against the pathogen or can generate antibodies that can be collected that are protective against infection by the pathogen. In addition, the invention relates to vaccines comprising composite antigens and to method for treating and preventing an infection.


Find Patent Forward Citations

Loading…